Institutional investors hold a majority ownership of BMY through the 71.78% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $7.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 22.5 Million shares of Bristol-Myers Squibb
CAPITAL RESEARCH & MANAGEMENT CO... Bought 15.3 Million shares of Bristol-Myers Squibb
WELLINGTON MANAGEMENT CO. LLP Bought 11.8 Million shares of Bristol-Myers Squibb